Curtin University Homepage
  • Library
  • Help
    • Log in

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Health and doping in elite-level cycling

    Access Status
    Fulltext not available
    Authors
    Lentillon-Kaestner, V.
    Hagger, Martin
    Hardcastle, S.
    Date
    2012
    Type
    Journal Article
    
    Metadata
    Show full item record
    Abstract

    The protection of the health of athletes is one of the three criteria taken into account when registering a substance in the World Anti-Doping Agency prohibited list. Nevertheless, in elite-level cycling, banned substance use is widespread. The present research adopted a psychological approach to examine how or whether perceived health risks influence elite-level cyclists' decisions to use banned substances. Sixteen semi-structured interviews were conducted with cyclists hoping to join a professional team (n=6), neo-professional cyclists (n=2), and former professional cyclists (n=8). Although an evolution was observed in the organization of doping and perceptions of doping over the last decade, the perceived health hazards did not influence, most of the time, decisions to use banned substances among the sample of cyclists. There was a systematization of exogenous substance use in the cycling environment and a trivialization of the side effects of the banned substances. Finally, younger cyclists were not concerned about the long-term health consequences of banned substances; they were more focused on the short-term performance-enhancing benefits. There is a need to implement more effective preventive programs to change athletes' attitudes toward doping and its health risks.

    Citation
    Lentillon-Kaestner, V. and Hagger, M. S. and Hardcastle, S. 2012. Health and doping in elite-level cycling. Scandinavian Journal of Medicine and Science in Sports. 22 (5): pp. 596-606.
    Source Title
    Scandinavian Journal of Medicine and Science in Sports
    DOI
    10.1111/j.1600-0838.2010.01281.x
    ISSN
    0905 7188
    URI
    http://hdl.handle.net/20.500.11937/29379
    Collection
    • Curtin Research Publications

    Related items

    Showing items related by title, author, creator and subject.

    • A comparison of caffeine versus pseudoephedrine on cycling time-trial performance
      Spence, Angela; Sim, M.; Landers, G.; Peeling, P. (2013)
      Both caffeine (CAF) and pseudoephedrine (PSE) are proposed to be central nervous system stimulants. However, during competition, CAF is a permitted substance, whereas PSE is a banned substance at urinary levels >150 μg · ...
    • Safer cycling in the urban road environment: study approach and protocols guiding an Australian study
      Stevenson, M.; Johnson, M.; Oxley, J.; Meuleners, Lynn; Gabbe, B.; Rose, G. (2014)
      Background: Much of the research into cyclist safety in Australia has focused on behaviour with less focus on the impact of the urban transport environment on cyclist safety. A greater understanding of the urban transport ...
    • Athletes’ Beliefs About and Attitudes Towards Taking Banned Performance-Enhancing Substances: A Qualitative Study
      Chan, Derwin; Hardcastle, S.; Lentillon-Kaestner, V.; Donovan, Robert; Dimmock, J.; Hagger, Martin (2014)
      Elite athletes’ beliefs about, and attitudes toward, taking banned performance enhancing substances were explored in 8 focus-group discussions with 57 athletes from 7 different sports. Discussion was initiated by 3 broad ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorsTitlesSubjectsDocument TypesThis CollectionIssue DateAuthorsTitlesSubjectsDocument Types

    My Account

    Log in

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Connect with Curtin

    • 
    • 
    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158